No Data
No Data
Express News | Zymo Research Says Court Denied QIAGEN GmbH's Partial Motion To Dismiss And In The Alternative, To Stay Certain Counterclaims Brought By Zymo
The Past Three-year Earnings Decline for Qiagen (NYSE:QGEN) Likely Explains Shareholders Long-term Losses
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday
QIAGEN Receives U.S. Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel, Expanding U.S. Syndromic Testing Portfolio
Life Sciences Tools Companies Get Additional Reprieve From NIH Funding Cuts
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 39% Undervaluation?
Unlock the Full List